Catabasis Pharma (CATB) Tops Q2 EPS by 4c

August 11, 2016 4:40 PM EDT
Get Alerts CATB Hot Sheet
Trade CATB Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Catabasis Pharma (NASDAQ: CATB) reported Q2 EPS of ($0.61), $0.04 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment